Traders assessing the "ctxr stock forecast 2025" should consider macroeconomic factors, including interest rate stability. A softer USD and steady bond yields could favor biotech valuations, with CTXR potentially outperforming its 2024 base due to attractive entry-level pricing. Rich Duprey has written about stocks and investing for the past 20 years. His articles have appeared on Nasdaq.com, The Motley Fool, and Yahoo! Finance, and he has been referenced by U.S. and international publications, including MarketWatch, Financial Times, Forbes, Fast Company, USA Today, Milwaukee Journal Sentinel, Cheddar News, The Boston Globe, L’Express, and numerous other news outlets. Select reference data provided by FactSet. Copyright © 2025 FactSet Research Systems Inc. The recent uptick in biotech venture funding bolsters the "ctxr stock forecast 2025", as stronger liquidity often fuels small-cap speculative runs. Should CTXR benefit from secondary market interest, price acceleration toward $1.65 is feasible.